vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Hilltop Holdings Inc. (HTH). Click either name above to swap in a different company.

Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 0.7%, a 12.3% gap on every dollar of revenue.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.

HCM vs HTH — Head-to-Head

Bigger by revenue
HTH
HTH
1.1× larger
HTH
$300.5M
$270.8M
HCM
Higher net margin
HTH
HTH
12.3% more per $
HTH
13.0%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
HTH
HTH
Revenue
$270.8M
$300.5M
Net Profit
$2.0M
$39.0M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
13.0%
Revenue YoY
-16.5%
Net Profit YoY
-83.6%
-12.4%
EPS (diluted)
$0.00
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
HTH
HTH
Q1 26
$300.5M
Q4 25
$270.8M
$329.9M
Q3 25
$330.2M
Q2 25
$277.7M
$303.3M
Q1 25
$324.5M
$318.5M
Q4 24
$301.1M
Q3 24
$305.5M
Q2 24
$305.7M
$297.0M
Net Profit
HCM
HCM
HTH
HTH
Q1 26
$39.0M
Q4 25
$2.0M
$41.6M
Q3 25
$45.8M
Q2 25
$455.0M
$36.1M
Q1 25
$11.9M
$42.1M
Q4 24
$35.5M
Q3 24
$29.7M
Q2 24
$25.8M
$20.3M
Gross Margin
HCM
HCM
HTH
HTH
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
HTH
HTH
Q1 26
Q4 25
-13.2%
16.1%
Q3 25
18.4%
Q2 25
-1.3%
16.3%
Q1 25
-5.0%
18.1%
Q4 24
14.7%
Q3 24
13.9%
Q2 24
-9.0%
10.0%
Net Margin
HCM
HCM
HTH
HTH
Q1 26
13.0%
Q4 25
0.7%
12.6%
Q3 25
13.9%
Q2 25
163.8%
11.9%
Q1 25
3.7%
13.2%
Q4 24
11.8%
Q3 24
9.7%
Q2 24
8.4%
6.8%
EPS (diluted)
HCM
HCM
HTH
HTH
Q1 26
$0.64
Q4 25
$0.00
$0.68
Q3 25
$0.74
Q2 25
$0.52
$0.57
Q1 25
$0.01
$0.65
Q4 24
$0.55
Q3 24
$0.46
Q2 24
$0.03
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
HTH
HTH
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$93.2M
$990.8M
Stockholders' EquityBook value
$1.2B
$2.2B
Total Assets
$1.8B
$15.7B
Debt / EquityLower = less leverage
0.08×
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
HTH
HTH
Q1 26
Q4 25
$1.4B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
Q3 24
Q2 24
$802.5M
Total Debt
HCM
HCM
HTH
HTH
Q1 26
$990.8M
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
HTH
HTH
Q1 26
$2.2B
Q4 25
$1.2B
$2.2B
Q3 25
$2.2B
Q2 25
$1.2B
$2.2B
Q1 25
$759.9M
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$740.1M
$2.1B
Total Assets
HCM
HCM
HTH
HTH
Q1 26
$15.7B
Q4 25
$1.8B
$15.8B
Q3 25
$15.6B
Q2 25
$1.8B
$15.4B
Q1 25
$1.3B
$15.8B
Q4 24
$16.3B
Q3 24
$15.9B
Q2 24
$1.3B
$15.6B
Debt / Equity
HCM
HCM
HTH
HTH
Q1 26
0.46×
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
HTH
HTH
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
HTH
HTH
Q1 26
Q4 25
$8.2M
$-38.7M
Q3 25
$273.0M
Q2 25
$-72.9M
$-234.6M
Q1 25
$40.3M
$5.8M
Q4 24
$273.9M
Q3 24
$515.6M
Q2 24
$-39.8M
$-435.3M
Free Cash Flow
HCM
HCM
HTH
HTH
Q1 26
Q4 25
$3.4M
$-55.5M
Q3 25
$271.0M
Q2 25
$-82.2M
$-234.6M
Q1 25
$32.5M
$5.0M
Q4 24
$266.8M
Q3 24
$513.8M
Q2 24
$-49.9M
$-437.3M
FCF Margin
HCM
HCM
HTH
HTH
Q1 26
Q4 25
1.2%
-16.8%
Q3 25
82.1%
Q2 25
-29.6%
-77.4%
Q1 25
10.0%
1.6%
Q4 24
88.6%
Q3 24
168.2%
Q2 24
-16.3%
-147.2%
Capex Intensity
HCM
HCM
HTH
HTH
Q1 26
Q4 25
1.8%
5.1%
Q3 25
0.6%
Q2 25
3.3%
0.0%
Q1 25
2.4%
0.3%
Q4 24
2.4%
Q3 24
0.6%
Q2 24
3.3%
0.7%
Cash Conversion
HCM
HCM
HTH
HTH
Q1 26
Q4 25
4.21×
-0.93×
Q3 25
5.96×
Q2 25
-0.16×
-6.50×
Q1 25
3.38×
0.14×
Q4 24
7.71×
Q3 24
17.36×
Q2 24
-1.54×
-21.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

HTH
HTH

Noninterest Income$188.4M63%
Net Interest Income$112.1M37%

Related Comparisons